MIT spinout Iterative Scopes has now raised $43.5m altogether from investors including Eli Lilly and Johnson & Johnson.

Iterative Scopes, a US-based precision medicine company focused on gastroenterology that is based on research at Massachusetts Institute of Technology (MIT), has completed a $30m series A round. The round was led by Obvious Ventures, with additional commitments from pharmaceutical firms Eli Lilly and Johnson & Johnson, the latter investing through corporate venturing arm Johnson…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.